Differentiation of recurrent nasopharyngeal carcinoma and skull base osteoradionecrosis by Epstein-Barr virus-derived latent membrane protein-1 gene

被引:18
作者
Hao, SP
Tsang, NM
Chang, KP
机构
[1] Chang Gung Mem Hosp, Dept Otolaryngol, Taipei, Taiwan
[2] Chang Gung Mem Hosp, Dept Radiat Oncol, Taipei, Taiwan
[3] Chang Gung Univ, Taipei, Taiwan
关键词
nasopharyngeal carcinoma; Epstein-Barr virus; latent membrane protein; osteoradionecrosis; recurrence;
D O I
10.1097/00005537-200104000-00017
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objectives: In patients with nasopharyngeal carcinoma (NPC), the differentiation between recurrent primary cancer and osteoradionecrosis (ORN) is clinically difficult. Epstein-Barr virus (EBV)-derived latent membrane protein-1 (LMP-1) has been demonstrated to be highly associated with NPC, The objective of this study is to define the role of the LMP-1 gene in the differential diagnosis of recurrent NPC and ORN, Study Design Prospective. Methods: From July 1998 to June 2000, 15 postirradiated patients with NPC mho were initially diagnosed to have skull base ORN underwent endoscopic sequestrectomy, The sequestra mere examined for the presence of the LMP-1 gene and cancer. Results: Two of 15 patients had recurrent cancer and only these two patients demonstrated a positive LMP-1 gene in their surgically removed sequestra The presence of the LMP-1 gene in the sequestrum coincided with biopsy-proven local recurrence. Conclusions: The LMP-1 gene is a potential marker to differentiate between recurrent NPC and ORN, The presence of the LMP-1 gene in patients with ORN may indicate local recurrence.
引用
收藏
页码:650 / 652
页数:3
相关论文
共 20 条
[1]   The role of brachytherapy in early-stage nasopharyngeal carcinoma [J].
Chang, JT ;
See, LC ;
Tang, SG ;
Lee, SP ;
Wang, CC ;
Hong, JH .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 36 (05) :1019-1024
[2]   Endoscopic management of skull base osteoradionecrosis [J].
Chang, KP ;
Tsang, NM ;
Chen, CY ;
Su, JL ;
Hao, SP .
LARYNGOSCOPE, 2000, 110 (07) :1162-1165
[3]   DETECTION OF EPSTEIN-BARR-VIRUS DNA-SEQUENCES IN NASOPHARYNGEAL CARCINOMA-CELLS BY ENZYMATIC DNA AMPLIFICATION [J].
CHANG, YS ;
TYAN, YS ;
LIU, ST ;
TSAI, MS ;
PAO, CC .
JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (11) :2398-2402
[4]   DETECTION OF EPSTEIN-BARR-VIRUS GENOME IN NASOPHARYNGEAL CARCINOMA BY IN-SITU DNA HYBRIDIZATION [J].
CHEN, CL ;
WEN, WN ;
CHEN, JY ;
HSU, MM ;
HSU, HC .
INTERVIROLOGY, 1993, 36 (02) :91-98
[5]  
DENG H, 1995, CHINESE MED J-PEKING, V108, P300
[6]   NUCLEOTIDE-SEQUENCE OF AN MESSENGER-RNA TRANSCRIBED IN LATENT GROWTH-TRANSFORMING VIRUS-INFECTION INDICATES THAT IT MAY ENCODE A MEMBRANE-PROTEIN [J].
FENNEWALD, S ;
VANSANTEN, V ;
KIEFF, E .
JOURNAL OF VIROLOGY, 1984, 51 (02) :411-419
[7]   Systematic management of osteoradionecrosis in the head and neck [J].
Hao, SP ;
Chen, HC ;
Wei, FC ;
Chen, CY ;
Yeh, ARM ;
Su, JL .
LARYNGOSCOPE, 1999, 109 (08) :1324-1327
[8]   NASOPHARYNGEAL CANCER - STUDY-III - A REVIEW OF 1206 PATIENTS TREATED WITH COMBINED MODALITIES [J].
HUANG, SC ;
LUI, LT ;
LYNN, TC .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1985, 11 (10) :1789-1793
[9]  
LIN SY, IN PRESS HEAD NECK
[10]   CLONAL PROLIFERATIONS OF CELLS INFECTED WITH EPSTEIN-BARR-VIRUS IN PREINVASIVE LESIONS RELATED TO NASOPHARYNGEAL CARCINOMA [J].
PATHMANATHAN, R ;
PRASAD, U ;
SADLER, R ;
FLYNN, K ;
RAABTRAUB, N .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (11) :693-698